Skip to content

Opening book details…

About this Medicine article

Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy by Pistilli, B.; Pluard, T.; Urruticoechea, A.; Farci, D.; Kong, A.; Bachelot, T.; Chan, S.; Han, H. S.; Jerusalem, G.; Urban, P.; Robinson, D.; Mouhaër, S. L.; Tomaso, E. D.; Massacesi, C.; Saura, C. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Pistilli, B.; Pluard, T.; Urruticoechea, A.; Farci, D.; Kong, A.; Bachelot, T.; Chan, S.; Han, H. S.; Jerusalem, G.; Urban, P.; Robinson, D.; Mouhaër, S. L.; Tomaso, E. D.; Massacesi, C.; Saura, C.
Publisher
Springer US; Springer-Verlag; Kluwer Academic Publishers; Springer Science and Business Media LLC (ISSN 0167-6806)
Published
2017
Field
Medicine (Health Sciences)

More by Pistilli, B.; Pluard, T.; Urruticoechea, A.; Farci, D.; Kong, A.; Bachelot, T.; Chan, S.; Han, H. S.; Jerusalem, G.; Urban, P.; Robinson, D.; Mouhaër, S. L.; Tomaso, E. D.; Massacesi, C.; Saura, C.

Browse all works by Pistilli, B.; Pluard, T.; Urruticoechea, A.; Farci, D.; Kong, A.; Bachelot, T.; Chan, S.; Han, H. S.; Jerusalem, G.; Urban, P.; Robinson, D.; Mouhaër, S. L.; Tomaso, E. D.; Massacesi, C.; Saura, C.